Status:
COMPLETED
Infiltration of Gadolinium Injection in Brain MR Scans Using Artificial Intelligence
Lead Sponsor:
Mayo Clinic
Conditions:
Magnetic Resonance Imaging
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research is to develop machine learning algorithms to analyze images from brain MRI to confirm that contrast agent has been correctly administered.
Eligibility Criteria
Inclusion
- Patients undergoing a MR brain without and with contrast examination on any GE or Siemens 1.5T and 3T MRI system within Mayo Clinic, Rochester, as part of their care plan.
Exclusion
- None
Key Trial Info
Start Date :
March 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 5 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05235646
Start Date
March 14 2022
End Date
April 5 2022
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905